LevyPA.Inborn errors of metabolism: part 1: an overview. Pediatr Rev. 2009;30:131-138.
2.
LevyPA.Inborn errors of metabolism: part 2: specific disorders. Pediatr Rev. 2009;30:e22-e28.
3.
Par BaroneRPellicoAPittalàAGasperiniS. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. Ital J Pediatr. 2018;44(suppl 2):121.
4.
SharmaSSabharwalJRDattaPSoodS.Clinical manifestation of Hurler syndrome in a 7 year old child. Contemp Clin Dent. 2012;3:86-89.
5.
WraithJE.The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child. 1995;72:263-267.
6.
Opoka-WiniaraskaVJureckaAEmerykATylki-SzymanskaA.Osteoimmunology in mucopolysaccharidoses type I, II, VI, VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation. Osteoarthritis Cartilage. 2013;21:1813-1823.
7.
ZafeiriouDIBatziosSP.Brain and spinal MR imaging findings in mucopolysaccharidosis: a review. AJNR Am J Neuroradiol. 2013;34:5-13.
8.
LawrenceRBrownJRLoreyFDicksonPICrawfordBEEskoJD.Glycan-based biomarkers for mucopolysaccharidoses. Mol Genet Metab. 2014;111:73-83.
9.
D’AcoKUnderhillLRangachariL, et al. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry. Eur J Pediatr. 2012;171:911-919.
